Probiotic supplement in healthy infants to study gut microbiota and immune function
Official title: Study on the Effects of Lactobacillus Paracasei LPB27 on Infant Gut Microbiota and Immune Regulation
Run by BYHEALTH Co., LTD · NCT07896083 · Data updated 2026-11-12
Giving a probiotic to healthy infants from birth up to 6 months old to see how it affects their gut bacteria and immune health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 0 Months to 6 Months |
| Sex | All |
| Enrollment | 370 (estimated) |
| Sponsor | BYHEALTH Co., LTD Industry-sponsored |
| Locations | 1 site (Dalian, Liaoning) |
| Status | Recruiting |
| Started | October 11, 2025 |
| Main results expected | July 11, 2027 |
| Study ends | August 25, 2027 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07896083 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are healthy, full-term infants aged 0-6 months whose guardians consent to participate and agree to avoid other probiotics during the study.
✕Probably not a fit
Infants with significant acute or chronic illnesses or those whose conditions may interfere with normal intestinal development may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests the effects of Lacticaseibacillus paracasei LPB27 on gut microbiota composition, growth, and immune-related outcomes in healthy full-term infants aged 0-6 months. The study also looks at defecation patterns and common gastrointestinal symptoms. Participants will receive the probiotic supplement with maltodextrin, with restrictions on other probiotic use during the study. The trial is conducted at Zhongshan Hospital affiliated with Dalian University, sponsored by BYHEALTH Co., Ltd, with no listed collaborators.
Why it matters
Potential benefit: If successful, the probiotic could support healthier gut microbiota and potentially modulate immune development in infancy.
How similar studies have gone: Previous probiotic studies in infants have shown microbiota and GI symptom modulation with certain strains, but outcomes are strain-specific and context-dependent.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. Infants born at full term and aged 0-6 months, whose overall health condition was determined to be good by the researchers; * 2\. There are no restrictions on the mode of delivery and feeding methods; * 3\. Agree not to consume probiotics other than the tested product or formula milk powder containing probiotics during the study period; * 4\. Parents or legal guardians voluntarily participate in this clinical trial and sign the informed consent form. Exclusion Criteria: * 1\. Suffering from severe acute or chronic coexisting diseases (cardiovascular, gastrointestinal, metabolic, endocrine, immune or any disease deemed contraindicated by the researchers); * 2\. Having a disease that might interfere with the researcher's observation of the normal development process of the infant's intestinal microecology. Such diseases include: acute infections (acute upper respiratory tract infection, acute diarrhea, etc.); autoimmune diseases (such as ulcerative colitis, Crohn's disease, etc.); intestinal surgeries (intussusception, intestinal obstruction, endoscopic examination, etc.), major surgeries (post-surgery for congenital heart disease, etc.), genetic metabolic diseases (such as cystic fibrosis), burns and severe trauma, energy metabolism-related diseases (diabetes, cerebral palsy, etc.), premature birth, tumors, diseases with abnormal intestinal structure development (megacolon, gastric torsion, etc.); * 3\. Having consumed probiotics or formula milk containing probiotics in the past two weeks; * 4\. Having used antibiotics in the past two months; * 5\. Having participated in drug clinical research in the past three months; * 6\. Refusing random grouping.
Where it's running
-
Zhongshan Hospital Affiliated to Dalian University
Dalian, Liaoning, China Recruiting
Study contacts
- Study coordinator: Ming Li
- Email: vivianmarat@163.com
- Phone: 180 1892 3363
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Growth, tolerance, and gut markers in healthy infants given dietary supplements
This study tests whether giving probiotic supplements to healthy newborns helps with weight gain and gut health compared with a placebo.
-
Preventing excessive crying and colic in newborns with a probiotic supplement of two L. reuteri strains
This will try giving healthy newborns a dietary supplement containing two L. reuteri probiotic strains plus vitamin D during their first three months to see if it reduces excessive crying and infantile colic compared with a placebo.
-
Dietary supplement in healthy infants
A double-blind, placebo-controlled study is testing whether a dietary supplement given to healthy term infants can change their gut microbiome compared with a placebo.
-
Effect of a New Infant Formula on Gut Health in Healthy Infants
A healthy, full-term infant formula is tested to see if it increases the good gut bacteria (Bifidobacterium) after 10 weeks compared with a standard formula.
-
Daily probiotic supplement for healthy newborns
We're testing whether giving a daily probiotic to healthy newborns from about two weeks to nine months helps their gut microbiome and overall health.
-
Effect of a High Fibre Fermented Diet on Breastfed Infant Gut Microbiome
This study is testing if a high fiber and fermented food diet for breastfeeding moms can positively affect the gut health of their infants.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.